Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01485731 · ClinicalTrials.gov registry record · Phase 1
Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer
A Phase 1 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT01485731: Completed Phase 1 study, sponsored by University of Miami.
NCT01485731 is a Phase 1 study that has completed, run by University of Miami. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01485731, a Phase 1 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation therapy for locally advanced cervical cancer.
Primary Outcome
Number of Patients with Adverse Events in Phase 1 Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy
Interventions
- DRUG Cisplatin
- RADIATION Brachytherapy
- DRUG Nelfinavir
- RADIATION Pelvic External Beam Radiation Therapy
- PROCEDURE Pharmacokinetic Sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-02 |
| Phase | Phase 1 |
What the finished NCT01485731 record still lists
NCT01485731 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 5 interventions - of which Cisplatin is the first listed.
NCT01485731 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01485731 about?
NCT01485731 is a clinical study titled "Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer". Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation therapy for locally advanced cervical cancer.
What is the current status of trial NCT01485731?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2012-01. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01485731?
The interventions under investigation include: Cisplatin (DRUG), Brachytherapy (RADIATION), Nelfinavir (DRUG), Pelvic External Beam Radiation Therapy (RADIATION), Pharmacokinetic Sampling (PROCEDURE).
Who is sponsoring clinical trial NCT01485731?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01485731's enrollment target sits among peer trials
8 1959th of 2000 higher than 29 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia